Back to search
FDAFDA · Food and drugs·Recall number D-1309-2022

Lorazepam Injection, USP, 2mg/mL, 1 mL vial, 25 vial per carton, Rx Only, Novaplus, Manufactured by Hikma Berkeley Heights, NJ 07922. Carton NDC# 0641-6048-25, Vial NDC# 0641-6048-01

Published August 17, 2022 · Recall initiated: July 11, 2022

Summary

FDA records drug Class II recall D-1309-2022, published August 17, 2022 and initiated July 11, 2022. Recalling firm: Hikma Pharmaceuticals USA Inc.; Status: Terminated; Reported quantity: 713,550 vials; Lot: Lot # 070088, exp. date 07/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications: Out-of-specification results observed for total related compounds during testing of retain samples.

What to do

Voluntary: Firm initiated · Letter

Get an email if LORAZEPAM has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
LORAZEPAM
Manufacturer
Hikma Pharmaceuticals USA Inc.
Distributor
Nationwide in the USA
Lot
Lot # 070088, exp. date 07/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Lorazepam Injection, USP, 2mg/mL, 1 mL vial, 25 vial per carton, Rx Only, Novaplus, Manufactured by Hikma Berkeley Heights, NJ 07922. Carton NDC# 0641-6048-25, Vial NDC# 0641-6048-01 recalled?

Yes. FDA published recall D-1309-2022 on August 17, 2022. Reported hazard: Failed Impurities/Degradation Specifications: Out-of-specification results observed for total related compounds during testing of retain samples.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: LORAZEPAM.